Blvr Valves denied for missing prior authorization by Humana?

Humana's specific coverage criteria for blvr valves are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Requires Prior Authorization for BLVR Valves — and How to Appeal

Bronchoscopic lung volume reduction (BLVR) using endobronchial valves is a high-cost, specialized procedure that Humana places on its prior-authorization required list. A prior-auth denial for BLVR means either: (a) authorization was not sought before the procedure was performed and is now being denied retrospectively, or (b) a prospective prior-authorization request was submitted but denied because the documentation did not satisfy Humana's coverage criteria.

For prospective denials, the appeal is a direct challenge to Humana's coverage determination. For retrospective denials, the appeal also involves demonstrating that the service was medically necessary and that any authorization failure was not the patient's fault — particularly relevant when a provider submitted the case and the patient had a reasonable expectation of coverage.

## Your Federal Appeal Rights

ACA §2719 and ERISA §503 guarantee the right to internal appeal and, after an adverse internal decision, to binding IRO external review. The internal appeal window is generally 180 days from the denial notice. After the final internal denial, you typically have four months to request external review. For patients with severe emphysema whose condition is deteriorating, expedited review compresses the decision timeline to 72 hours.

## Documentation to Gather

• Humana's BLVR coverage policy: Download the current version from Humana's provider or member portal. Every criterion in that policy must be addressed with corresponding chart evidence. Common criteria include: emphysema severity on pulmonary function testing, emphysema distribution on CT, collateral ventilation assessment, prior optimization of medical therapy, and pulmonary rehabilitation completion.
• Pulmonary function test results: Your actual test reports (spirometry, lung volumes, DLCO) — referenced by date from the chart.
• CT chest report: A radiology report documenting emphysema type, distribution, and severity — ideally using language that aligns with Humana's policy criteria.
• Collateral ventilation assessment report: Documentation of the Chartis catheter-based assessment confirming absence of collateral ventilation in the target lobe. Missing this document is one of the most common reasons BLVR prior-auth requests are denied.
• Medical therapy and rehabilitation records: Confirmation the patient completed pulmonary rehabilitation and is on maximally tolerated medical therapy — per the treating physician's chart notes and rehabilitation program records.
• Prescriber medical-necessity letter: A structured letter that walks through each criterion in Humana's policy and maps it explicitly to the evidence above.

## Criteria-Mapping Structure

Print Humana's coverage policy criteria as a numbered list. For each criterion, provide: the criterion text, the supporting document, the document date, and a one-sentence summary of what it shows. This format lets the Humana reviewer — or the IRO reviewer — verify compliance criterion by criterion, which significantly improves approval rates.